Literature DB >> 16221162

A case of acute humoral rejection in liver transplantation: successful treatment with plasmapheresis and mycophenolate mofetil.

Anthony Rostron1, Vaughan Carter, Mbithe Mutunga, Gary Cavanagh, Criostoir O'Suilleabhain, Alistair Burt, Bryon Jaques, David Talbot, Derek Manas.   

Abstract

We present a case of a 23-year-old female who underwent orthotopic liver transplantation (OLTx) for biliary atresia, 22 years after a failed Kasai operation. Unusually, her postoperative course was complicated by severe acute humoral rejection. In this case report, we discuss her management as well as the role of plasmapheresis in treating allograft dysfunction secondary to acute humoral rejection in liver transplant patients.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16221162     DOI： 10.1111/j.1432-2277.2005.00200.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN： 0934-0874            Impact factor:   3.782


  6 in total

1.  The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.

Authors:  A I Musat; R M Agni; P Y Wai; J D Pirsch; D F Lorentzen; A Powell; G E Leverson; J M Bellingham; L A Fernandez; D P Foley; J D Mezrich; A M D'Alessandro; M R Lucey
Journal:  Am J Transplant       Date:  2011-03       Impact factor: 8.086

2.  Bortezomib for acute antibody-mediated rejection in liver transplantation.

Authors:  F Paterno; M Shiller; G Tillery; J G O'Leary; B Susskind; J Trotter; G B Klintmalm
Journal:  Am J Transplant       Date:  2012-06-08       Impact factor: 8.086

3.  Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantation.

Authors:  Nassim Kamar; Laurence Lavayssière; Fabrice Muscari; Janick Selves; Céline Guilbeau-Frugier; Isabelle Cardeau; Laure Esposito; Olivier Cointault; Marie Béatrice Nogier; Jean Marie Peron; Philippe Otal; Marylise Fort; Lionel Rostaing
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

Review 4.  The Role of Humoral Alloreactivity in Liver Transplantation: Lessons Learned and New Perspectives.

Authors:  Elaine Y Cheng
Journal:  J Immunol Res       Date:  2017-01-09       Impact factor: 4.818

5.  Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation?

Authors:  Marcio F Chedid; Emilio Rodrigo
Journal:  Transplant Direct       Date:  2019-09-23

6.  Acute liver failure secondary to acute antibody mediated rejection after compatible liver transplant: A case report.

Authors:  Todd J Robinson; James B Hendele; Idoia Gimferrer; Nicolae Leca; Scott W Biggins; Jorge D Reyes; Lena Sibulesky
Journal:  World J Hepatol       Date:  2022-01-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.